Insurance and coverage
Ask the plan to name the use it covers
Put the exact medicine and the reason for prescribing it into the coverage question. Ask your plan to answer for that combination.
Ask before treating coverage as settled
A formulary is your plan’s list of covered drugs. With prior authorization, you ask the plan to agree to cover a prescription before you fill it.
An approved use can make a medicine eligible for Medicare Part D coverage, but the plan’s formulary and prior authorization still matter, as reviewed in September 2026.
Medicare has a rule and a temporary route
At the September 2026 check, basic Medicare Part D still did not include drugs prescribed solely for weight loss.
Medicare’s temporary GLP-1 Bridge helps eligible people obtain certain weight medicines, including pills and injections. It charges the patient $50 for a month’s supply. It began on July 1, 2026 and is due to end on December 31, 2027.
The Bridge uses a separate payment process from normal Part D drug coverage. For 2026, Medicare put a central processor in charge of approving requests and paying pharmacies.
Ask your prescriber to send the Bridge approval request, and ask the pharmacy how it handles a Bridge prescription.
Body mass index, shortened to BMI, compares your weight with your height. The health and BMI checks refer to when you began treatment, so ask your prescriber to compare those records with the following limits:
- For the weight test alone, BMI must reach 35; higher numbers also meet that test.
- At 30 or higher, BMI can qualify alongside certain health problems. These include a specific type of heart failure or kidney disease lasting over time and classed as stage 3a or worse. Blood pressure that stays high while taking two blood-pressure medicines can also qualify: the upper reading must exceed 140, or the lower reading must exceed 90. Your prescriber must check that your heart diagnosis or kidney stage is the one accepted.
- At a BMI starting from 27, the health conditions are a previous stroke or heart attack, pre-diabetes, or disease of the limb arteries with symptoms.
Treatment also requires ongoing changes to eating and activity as part of a structured plan. Anyone who obtained a GLP-1 drug through Part D during 2026 is excluded from the Bridge for 2026. The September 2026 information did not yet say how earlier use would affect eligibility in 2027.
People with type 2 diabetes go through the ordinary Part D route rather than the Bridge, under the September 2026 eligibility rules.
Use the program’s official eligibility details with your prescriber; a headline price is too little to decide access.
Keep the next quote specific
Ask any other insurer about both the named drug and your reason for taking it. If the plan refuses to pay, ask for its reason in writing and how to request a review.